Food and Drug Administration, Pharmacology, Physicians and Recruitment

Search:

DAY

WEEK

MONTH

YEAR

Select your country:
Sign up | Log in

Food and Drug Administration

Pharmacology

Physicians

Recruitment

The potential of virtual reality-based therapy for serious mental disorders

Pharmaceutical Technology

AUGUST 12, 2022

In June this year, it was announced that the US Food and Drug Administration (FDA) had granted UK-based OxfordVR a breakthrough device designation for its gameChangeVR treatment to deliver immersive cognitive behaviour therapy (CBT) to people suffering from schizophrenia and other mental illnesses.

Food and Drug Administration

Food and Drug Administration Pharmacology Side effects Physicians

Nevro Announces FDA Approval of HFX iQ™ Spinal Cord Stimulation System to Personalize the Treatment of Chronic Pain

Legacy MEDSearch

OCTOBER 13, 2022

Food and Drug Administration (FDA) for the Senza HFX iQ spinal cord stimulation (SCS) system. With HFX iQ, our goal is to provide physicians and patients the personalization needed to achieve and maintain the best possible long-term outcomes. We believe HFX iQ represents the future of SCS therapy.”

FDA

FDA Food and Drug Administration Recruitment Pharmacology

Pharma Rep Focus

The potential of virtual reality-based therapy for serious mental disorders

Nevro Announces FDA Approval of HFX iQ™ Spinal Cord Stimulation System to Personalize the Treatment of Chronic Pain

Stay Connected